Tirzepatide Samples: Compounded & Brand-Name Programs (2026)
Tirzepatide is the active ingredient in Eli Lilly's Zepbound (weight management) and Mounjaro (Type 2 diabetes), plus a post-2024 compounded market that has narrowed significantly since FDA removed tirzepatide from the drug shortage list.
Tirzepatide is the most effective pharmaceutical weight-loss agent the FDA has approved — SURMOUNT-1 showed 20.9% mean body-weight reduction at the 15 mg dose — so "tirzepatide samples" searches are concentrated and commercially intense. What people mean when they search it varies sharply by their prior knowledge: some want Zepbound or Mounjaro specifically, many want compounded tirzepatide at the lowest price, a few are looking for the best cash-pay brand path.
This guide maps all three lanes: how Lilly's savings card and LillyDirect programs work in 2026, how the compounded market has re-organized since the shortage delisting, and which telehealth programs actually deliver on their tirzepatide access claims.
What's actually available: Tirzepatide samples in 2026
Three paths for people typing “tirzepatidesamples” — what they actually mean, typical cost, and who each path fits.
| Path | What it actually is | Typical cost | Best for |
|---|---|---|---|
| Compounded tirzepatide | 503A/503B pharmacy preparation against individual prescription; narrower market post-2024. | $249–$449 / month all-in | Cash-pay patients where brand-name channels don't fit |
| LillyDirect vials (brand cash) | Eli Lilly's direct-to-patient pharmacy for brand-name Zepbound single-dose vials. | $399 (2.5/5 mg) to $549 (10 mg) / 28-day supply | Cash-pay patients who want brand Zepbound for weight management |
| Brand Zepbound or Mounjaro (savings card) | Manufacturer copay assistance for commercially insured patients. | $25 / 28-day supply (covered plan) | Insured patients whose plan covers the relevant indication |
How Tirzepatide sample programs actually work
What changed for compounded tirzepatide after October 2024
FDA removed tirzepatide from the shortage list in October 2024 following resolved Lilly supply. 503A compounding of tirzepatide narrowed sharply — the shortage exception that justified large-scale production ended. Personalization compounding (documented clinical need for a non-commercial preparation) and 503B outsourcing continue under specific justifications. Reputable programs adjusted their offerings; the fringe market largely exited under regulatory pressure.
How LillyDirect's vial pricing actually compares to compounded
LillyDirect's $399/month entry price for brand-name Zepbound vials (2.5 mg or 5 mg) is within $150 of many compounded tirzepatide programs. For patients who value the FDA-approved product wrapper, that's a small premium. At the 10 mg dose, LillyDirect runs $549/month — above most reputable compounded programs but below the $1,086 retail cash price. LillyDirect is deliberately priced to compete with the compounded market.
When savings cards beat everything else
If you have commercial insurance and your plan covers the relevant tirzepatide indication (Mounjaro for diabetes, Zepbound for weight management), the savings card at $25/month is cheaper than any compounded or direct-cash program. Savings card eligibility requires commercial insurance specifically; Medicare, Medicaid, VA, and Tricare patients are excluded from all manufacturer cards by federal law.
Telehealth providers with clean tirzepatide workflows
Ro, Found, WeightWatchers Clinic, Hims, and Mochi all run tirzepatide workflows in 2026. The distinguishing factor is whether they have direct LillyDirect referral integration (faster cash-pay starts) and whether they handle both brand and compounded depending on patient fit. The telehealth-plus-compounded specialists (Henry Meds, LifeMD) generally don't offer brand Zepbound because their pricing model is built around the compounded channel.
Tirzepatide is the first obesity drug where the manufacturer's cheapest legitimate channel is close enough to compounded pricing to change the question.
Top providers offering Tirzepatide or the compounded alternative
Providers we've verified currently support a clinically appropriate Tirzepatide path. Pricing and availability vary by state. Every link is an affiliate link tracked through Impact Engine — see our disclosure.
| Rank | Provider | Best for | Sample type | Editor | Readers | Action |
|---|---|---|---|---|---|---|
| #1 | Henry Meds Compounded Semaglutide · Compounded Tirzepatide | best-for-compounded | telehealth | 4.6 / 5 | — | See offer |
| #2 | Mochi Health Compounded Semaglutide · Compounded Tirzepatide | best-for-clinical-support | telehealth | 4.4 / 5 | — | See offer |
| #3 | Ro Body Semaglutide · Tirzepatide | best-for-branded-rx | telehealth | 4.3 / 5 | — | See offer |
| #4 | Sesame Care Semaglutide · Tirzepatide | best-for-one-time-visit | telehealth | 4.2 / 5 | — | See offer |
| #5 | Found Semaglutide · Tirzepatide | best-for-insurance-coverage | telehealth | 4.0 / 5 | — | See offer |
| #6 | LifeMD Semaglutide · Tirzepatide | best-for-regulated-provider | telehealth | 4.0 / 5 | — | See offer |
| #7 | WeightWatchers Clinic Semaglutide · Tirzepatide | best-for-lifestyle-bundle | telehealth | 3.9 / 5 | — | See offer |
Henry Meds
Flat-rate compounded GLP-1 with a free telehealth consult to see if you qualify.
- ✓ Free intake consult
- ✓ Flat monthly price, no insurance needed
- ✓ No long-term contract
- − Not available in all states
- − Supply constraints during GLP-1 shortages
- − Compounded only (no branded Ozempic/Wegovy)
Mochi Health
Compounded GLP-1 with a dietitian-led program and insurance-billing option.
- ✓ Includes dietitian visits
- ✓ Insurance billing available
- ✓ Strong clinical team
- − Higher price than cash-only peers
- − Intake can take several days
- − US only
Ro Body
Major branded-Rx telehealth with a dedicated GLP-1 weight-loss program.
- ✓ Branded Wegovy / Zepbound when available
- ✓ Insurance coordination support
- ✓ Established national brand
- − Higher monthly cost
- − Intake and shipping slower than lean competitors
- − Not all medications in stock in all states
Sesame Care
A la carte telehealth where you pay per visit and get real GLP-1 prescriptions at list pricing.
- ✓ No subscription or recurring fee
- ✓ Pay once for the consult
- ✓ Use your own pharmacy + GoodRx
- − Medication cost is separate
- − No built-in coaching or support
- − Availability varies by state
Found
Weight-loss program that coordinates branded and compounded GLP-1 based on what your insurance covers.
- ✓ Handles prior authorizations
- ✓ Branded or compounded based on coverage
- ✓ Integrated coaching
- − Cost higher than cash-only peers
- − PA process can take weeks
- − Program requires 3-month commitment
Tirzepatide cost in 2026: every legitimate price path
What you'll actually pay depends on insurance, the path you take, and whether you stay on the brand-name drug. Here's the real money:
| Path | First month | Ongoing | Notes |
|---|---|---|---|
| Compounded tirzepatide (reputable) | $199–$349 (promo) | $299–$449/mo | Telehealth-bundled; pharmacy disclosed; state-licensed. |
| LillyDirect Zepbound vials (cash) | $399 | $399–$549/mo by dose | Direct-to-patient brand cash channel. |
| Zepbound savings card (covered plan) | $25 | $25/mo until annual cap | Commercial insurance + weight-management PA required. |
| Mounjaro savings card (covered plan) | $25 | $25/mo until annual cap | Commercial insurance + Type 2 diabetes indication. |
| Retail brand cash (either) | $1,069–$1,086 | Same | Pen formulation; no insurance or manufacturer assistance. |
What to expect on Tirzepatide: your first weeks
Tirzepatide titration is monthly: 2.5 mg weekly for 4 weeks, stepping up to 5, 7.5, 10, 12.5, and 15 mg. Most patients stabilize at 10 or 15 mg for maintenance. The titration cadence is the same across Zepbound, Mounjaro, and compounded tirzepatide programs.
Clinical response timeline differs by indication. Diabetes patients see meaningful A1C reduction at 8–12 weeks. Weight-management patients see appetite suppression in week 2, visible weight change by week 6–8, and continued weight loss through the 72-week trial duration.
GI tolerability is the dominant clinical challenge. Nausea, constipation, and reflux cluster at each dose escalation. Clinicians experienced with tirzepatide often slow the titration cadence — staying longer at the 5 mg or 7.5 mg dose — when patients report persistent side effects.
Clinical evidence behind Tirzepatide
Tirzepatide received FDA approval for diabetes (as Mounjaro) in May 2022 and for weight management (as Zepbound) in November 2023. SURMOUNT-1 (2022) showed 20.9% mean weight loss at the 15 mg dose over 72 weeks — the largest mean pharmaceutical weight-loss response the FDA has approved. SURPASS-2 showed tirzepatide superior to semaglutide 1.0 mg for A1C reduction in diabetes. SURMOUNT-CV (ongoing) is evaluating cardiovascular outcomes.
Tirzepatideside effects & who shouldn't take it
This is not medical advice. Discuss every medication decision with a licensed clinician who knows your full medical history.
Common side effects
- •Nausea (very common, peaks at dose escalation)
- •Diarrhea or constipation
- •Vomiting at the 5 mg and 7.5 mg steps
- •Decreased appetite
- •Injection-site reactions
- •Rare but serious: pancreatitis, gallbladder disease, MTC boxed warning
Who shouldn't take Tirzepatide
- •Personal or family history of medullary thyroid carcinoma
- •Multiple endocrine neoplasia syndrome type 2
- •Pregnancy or planned pregnancy within 2 months
- •Severe pancreatitis history
- •Current eating disorder not in remission
Eligibility for Tirzepatide
- •For Zepbound: BMI ≥30, or BMI ≥27 with weight-related comorbidity
- •For Mounjaro: Type 2 diabetes diagnosis
- •No contraindications (thyroid carcinoma history, MEN 2, severe pancreatitis)
- •Commercial insurance for savings card; federal plan enrollees excluded
Tirzepatide samples: frequently asked
Is compounded tirzepatide the same as Zepbound or Mounjaro?
Same active ingredient (tirzepatide), different legal and regulatory category. Brand Zepbound and Mounjaro are FDA-approved products. Compounded tirzepatide is a pharmacy preparation against an individual prescription.
Is compounded tirzepatide still legal in 2026?
Individual-patient compounding under 503A personalization rules and 503B outsourcing continue. The large-scale shortage-based compounding that dominated 2023–2024 narrowed when FDA removed tirzepatide from the shortage list in October 2024.
Are tirzepatide samples actually free?
Eli Lilly does not distribute consumer-facing free tirzepatide samples. The closest consumer-accessible programs are the savings cards ($25/month for eligible insured), LillyDirect vials ($399+ cash), and reputable compounded programs.
How much is tirzepatide without insurance?
LillyDirect's brand-name vials start at $399/month for low doses and reach $549/month at 10 mg. Retail pharmacy cash is $1,069–$1,086 for the pen formulation. Compounded tirzepatide runs $249–$449/month depending on the program and dose.
Is tirzepatide more effective than semaglutide?
In trial results, tirzepatide at 15 mg produced larger mean weight loss (20.9% at 72 weeks) than semaglutide at 2.4 mg (14.9% at 68 weeks). In diabetes, SURPASS-2 showed tirzepatide superior to semaglutide 1.0 mg for A1C reduction.
Can I switch from compounded tirzepatide to Zepbound?
Yes, with a new prescription. Clinicians typically transition at an equivalent dose; some slow the titration by one step to ease the switch.
Does Medicare cover tirzepatide?
Medicare Part D often covers Mounjaro for Type 2 diabetes. Medicare does not cover weight-loss drugs (Zepbound) by statute as of 2026. Savings cards cannot be used with Medicare.
What's the difference between Zepbound vials and pens?
Same drug, different presentation. The pen is pre-filled and auto-injects. The vial requires you to draw the dose with a separate syringe. Vials are only sold through LillyDirect at a lower cash price; retail pharmacies typically only stock the pen.